The Philadelphia Eagles seemed to bend the rules a bit during their 20-17 road victory over the Kansas City Chiefs on Sunday. Specifically, there were a few instances during short-yardage tush push ...

A new series of Labubus is about to hit the market, and the company's big announcement introduces a mini version of the popular accessory. Pop Mart's new "THE MONSTERS Pin for Love Series" Labubu ...

Unity is pinning hopes for revenue growth on the new AI-powered ads platform Vector after it helped deliver 15% sequential growth in the company’s ads business in Q2. The firm, which has engaged in ...

Amazon Web Services Inc. is rolling out a new set of tools designed to help customers build artificial intelligence agents. Swami Sivasubramanian (pictured), the cloud giant’s vice president of ...

The "tush push" is here to stay. An effort to ban the controversial football play failed to get enough votes among the NFL teams gathered in Minneapolis Wednesday, with the Philadelphia Eagles among ...

On the eve of the Spring League Meeting, an alteration has been introduced to one of the most anticipated decisions on a potential rule change. A revised proposal to ban the tush push play has been ...

A push-up is a body-weight exercise that builds strength in your chest, arms and shoulders. As you lower your chest and press back up, you challenge your core strength and stability. The exercise also ...

How many push-ups can you do — and how does that stack up with others your age? That was the question posed by "FOX & Friends," which invited viewers to send in their own videos showing their push-up ...

Drop and give us… well, read on for how many. Your ability to do push-ups indicates more than just how muscular your arms are — the number you can do also offers clues about your overall health. “A ...

Humane announced on Tuesday that most of its assets have been acquired by HP for $116 million. The hardware startup is immediately discontinuing sales of its $499 AI Pins. Humane alerted customers who ...

Amid a broader push to beef up cell and gene therapy manufacturing capacity in Europe, Novartis has opened the doors to a €40 million ($41.2 million) viral vector facility in Mengeš, Slovenia. The new ...